


| Key | % Net Assets |
|---|---|
| 8.8% | |
| 6.3% | |
| 5.8% | |
| 5.7% | |
| 73.4% |
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline | 8.8% |
| BP | 6.3% |
| Royal Dutch Shell 'B' | 5.8% |
| BT | 5.7% |
| British Energy | 5.6% |
| Vodafone | 4.7% |
| AstraZeneca | 4.5% |
| Imperial Tobacco | 4.4% |
| Reynolds American | 4.1% |
| British Airways | 4.0% |
| Key | % Net Assets |
|---|---|
| 16.70% | |
| 14.30% | |
| 13.30% | |
| 12.60% | |
| 11.80% |
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 30/01/1998 |
|---|---|
| Fund Manager | Martin Walker |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | 500 |
| Additional | 100 |
| Savings | 20 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | -0.01 |
You are here: research